Sanjivani Paranteral Ltd (531569) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 531569 | NSE: | Pharmaceuticals & Drugs | Small Cap

Sanjivani Paranteral Share Price

210.15 -7.25 -3.33%
as on 05-Dec'25 12:04

Sanjivani Paranteral Ltd (531569) Stock Analysis: Valuation, Latest Results, Financial Ratios & DeciZen Rating

BSE: 531569 | NSE: | Pharmaceuticals & Drugs | Small Cap

DeciZen - make an informed investing decision on Sanjivani Paranteral

Based on:

Overall Rating
Login to view analysis. M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality


Login to view analysis.

2. Valuation


Login to view analysis.

3. Price Trend


Login to view analysis.

Sanjivani Paranteral stock performance -

Key Ratios
mw4me loader
P/E Ratio (SA):
35.81
Market Cap:
267.1 Cr.
52-wk low:
170
52-wk high:
397

Is Sanjivani Paranteral Ltd an attractive stock to invest in?


Login to view analysis.

10 Year X-Ray of Sanjivani Paranteral: Login to view analysis.

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Sanjivani Paranteral Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % -7.3%-33%-227.3%0%-266%266.4%0%0%55.3%30.2%-
Value Creation
Index
-1.5NANANANA18.0NANA3.01.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 11532.71825.116.425.130.635.554.470.169
Sales YoY Gr.--71.7%-45%39.7%-34.8%53.4%22%15.9%53.3%28.8%-
Adj EPS -25.2-46-90-3.7-3.21.54.74.256.46.1
YoY Gr.-NANANANANA214.8%-10.9%20.3%26.4%-
BVPS (₹) 29.7-14.8-89.6-80-82.9-52.8-7.6-3.122.130.836.5
Adj Net
Profit
-14.9-27.2-53.1-2.2-1.91.34.74.25.97.67
Cash Flow from Ops. 0.59.63.12.5-0.20.68.54.7-10.7-0.2-
Debt/CF from Ops. 139.76.315.819.4-280.1790.70.5-0.1-23.6-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -5.4%33.8%31.8%28.8%
Adj EPS NANA10.7%26.4%
BVPS0.4%NANA39.3%
Share Price 13.2% 83.3% 73.2% -30.6%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
-60-618.2172.54.43.9-2.7-17.9-78.447.32318
Op. Profit
Mgn %
-4.8-70.4-289.8-7-3.48.513.914.814.714.714.6
Net Profit
Mgn %
-12.9-83.1-295.5-8.7-11.35.115.311.810.810.810.8
Debt to
Equity
3.6-6.9-0.9-1-1-1-0.8-0.800.20.1
Working Cap
Days
28472264917117913312812112416394
Cash Conv.
Cycle
221567420-105-169-112-90-8203158

Recent Performance Summary

Login to view analysis.
Login to view analysis.

Latest Financials - Sanjivani Paranteral Ltd.

Standalone Consolidated
TTM EPS (₹) 6.1 6.1
TTM Sales (₹ Cr.) 68.9 68.9
BVPS (₹.) 36.5 36.5
Reserves (₹ Cr.) 33 33
P/BV 5.96 5.96
PE 35.81 35.83
From the Market
52 Week Low / High (₹) 170.00 / 396.95
All Time Low / High (₹) 1.76 / 396.95
Market Cap (₹ Cr.) 267
Equity (₹ Cr.) 12.3
Face Value (₹) 10
Industry PE 40.7

Management X-Ray of Sanjivani Paranteral:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Sanjivani Paranteral - Standalone Basis

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Event Update

Login/Register to view analysis.

Analyst's Notes

data not found
No data found!

Key Ratios of Sanjivani Paranteral

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales115331825162531355470
Operating Expenses 121567027172326304660
Manufacturing Costs2221123345
Material Costs11328251591512192840
Employee Cost 3332223345
Other Costs 42340844851010
Operating Profit -6-23-52-2-1245810
Operating Profit Margin (%) -4.8%-71.2%-290.0%-7.0%-3.4%8.5%13.9%14.8%14.7%14.7%
Other Income 1301002111
Interest 9500100001
Depreciation 1111111111
Exceptional Items 0000000000
Profit Before Tax -15-26-53-2-2155810
Tax -0-0-0-0-0-00012
Profit After Tax -15-26-53-2-215568
PAT Margin (%) -12.7%-80.3%-295.0%-8.2%-10.4%5.7%15.8%12.7%11.3%11.6%
Adjusted EPS (₹)-24.8-44.5-90.0-3.5-2.91.74.94.55.36.8
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%7%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund 18-9-53-47-49-45-8-32637
Share Capital 66666810101212
Reserves 12-15-59-53-55-53-18-131425
Minority Interest0000000000
Debt6157454545423115
Long Term Debt12748853115
Short Term Debt4950413737370000
Trade Payables63121211111114615
Others Liabilities 982189121210118
Total Liabilities 93602518161918214365

Fixed Assets

Gross Block22222222222223242738
Accumulated Depreciation9111213141415161718
Net Fixed Assets 131110988781021
CWIP 0000000000
Investments 0000000003
Inventories20102121251010
Trade Receivables4832551752517
Cash Equivalents 00000000102
Others Assets 127735446913
Total Assets 93602518161918214365

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity 01032-0195-11-0
PBT -15-17-53-2-2155810
Adjustment 962121-1111
Changes in Working Capital 6215530-24-1-18-10
Tax Paid -000-0-0-0-0-0-1-1
Cash Flow From Investing Activity -10-00-0-0-1-1-12-6
Capex -10-00-0-0-1-1-3-11
Net Investments 00000000-98
Others 000000000-3
Cash Flow From Financing Activity -1-10-3-20-0-8-4236
Net Proceeds from Shares 00000320252
Net Proceeds from Borrowing 8-5-34100000
Interest Paid -8-5-0-0-1-0-0-0-0-1
Dividend Paid 0000000000
Others 000-60-3-9-3-25
Net Cash Flow -1-0000-00-000

Finance Ratio

PARTICULARSMar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)-58.98N/AN/AN/AN/AN/AN/AN/A54.0825.92
ROCE (%)-7.28N/AN/AN/AN/AN/AN/AN/A55.3230.22
Asset Turnover Ratio1.120.430.421.170.971.471.661.811.691.31
PAT to CFO Conversion(x)N/AN/AN/AN/AN/A11.81-1.83-0
Working Capital Days
Receivable Days18244637876705568352255
Inventory Days6816812421251816365052
Payable Days306010828946126432724712595

Sanjivani Paranteral Ltd Stock News

Sanjivani Paranteral Ltd FAQs

The current trading price of Sanjivani Paranteral on 05-Dec-2025 12:04 is ₹210.2.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 04-Dec-2025 the market cap of Sanjivani Paranteral stood at ₹267.1.
The latest P/E ratio of Sanjivani Paranteral as of 04-Dec-2025 is 35.81.
The latest P/B ratio of Sanjivani Paranteral as of 04-Dec-2025 is 5.96.
The 52-week high of Sanjivani Paranteral is ₹396.9 and the 52-week low is ₹170.0.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sanjivani Paranteral is ₹68.92 ( Cr.) .

About Sanjivani Paranteral Ltd

Sanjivani Parenteral was established in 1997 by A H Khemka, Ashwin Khemka and Somesh Khemka, under the technical direction of Mahendra Kalwankar. It is a research-based, international pharmaceutical company that provides a wide range of high quality products and services at affordable prices. The core product range of the company’s products includes oral solids, small volume parenterals and sterile powder formulations.

The company has grown many folds and aspires to be a respected research-based company. With its diverse product portfolio, it is rapidly expanding its reach to the global marketplace, riding on its success in India and in the world’s emerging and developed markets.

After establishing itself in India, Sanjivani has extended its reach globally by entering the markets of Asia, Europe, Africa and Latin America.  The company has active presence in countries like Russia, Ukraine, Uzbekistan, Turkmenistan, Fiji, Vietnam, Sri Lanka, Nepal, Malaysia, Thailand, Nigeria and Peru, to name a few.  Sanjivani Parenteral has also got its plant approved by the registration authorities of Congo, Sudan and Sri Lanka. It is making its presence felt in the world market now, through leveraging its manufacturing capacity, quality of products and international alliances.

International business contributes about 30% of the company’s revenue and is set to grow to more than 50% in the coming two years. This includes the sales of Sanjivani’s own brands and the revenue from the contract manufacturing services that the company provides to its overseas clients. The company is in the making of a strong base to broaden its horizons. 

Sanjivani has been a regular supplier to the armed forces’ hospitals in India. Furthermore, many government and private hospitals have availed of the products and services offered by Sanjivani across the country.  The company also has its own marketing operations in India and boasts of over 1000 distributors all over India.

Products

  • Therapeutic Products
  • Animal Products
  • Key Products
  • Oral Solids
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×